The Venture Codex Logo

The Venture Codex

Overview

Antibody-focused precision oncology company.

Total Raised

$30 M

Rounds

1

Links

Verticals

Life Science
Oncology
Therapeutics

Investment History

  1. Series A

    Dec 2022

    $30M

Team

Anna Kohlmann

Co-Founder & Chief Technology Officer

Ken Geles

Co-Founder & Vice President of Discovery Biology